project id: TCGA-UCEC; case submitter id: TCGA-EY-A54A; source center: 23; state: released; a260 a280 ratio: 1.88; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.46; rna integrity number: 9.0; age at index: 67; days to birth: -24822; ethnicity: not hispanic or latino; gender: female; race: black or african american; vital status: Alive; year of birth: 1945; age at diagnosis: 24822; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 447.0; figo stage: Stage IIIC2; icd 10 code: C54.9; last known disease status: not reported; morphology: 8380/3; primary diagnosis: Endometrioid adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Corpus uteri; synchronous malignancy: No; tissue or organ of origin: Corpus uteri; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: yes; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 105; days to sample procurement: 0; initial weight: 500.0; portion submitter id: TCGA-EY-A54A-01A-11; percent lymphocyte infiltration: 5.0; percent monocyte infiltration: 3.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 0.0; percent stromal cells: 0.0; percent tumor cells: 100.0; percent tumor nuclei: 65.0;